Hershman DL - Search Results

1

Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study.

Vin-Raviv N, Hillyer GC, Hershman DL, Galea S, Leoce N, Bovbjerg DH, Kushi LH, Kroenke C, Lamerato L, Ambrosone CB, Valdimorsdottir H, Jandorf L, Mandelblatt JS, Tsai WY, Neugut AI. Vin-Raviv N, et al. Among authors: hershman dl. J Natl Cancer Inst. 2013 Apr 17;105(8):563-72. doi: 10.1093/jnci/djt024. Epub 2013 Feb 21. J Natl Cancer Inst. 2013. PMID: 23434900 Free PMC article.

2

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.

Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20. Cancer J Sci Am. 2000. PMID: 10696733

3

Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.

Hershman D, Sundararajan V, Jacobson JS, Heitjan DF, Neugut AI, Grann VR. Hershman D, et al. J Clin Oncol. 2002 Jan 1;20(1):9-16. doi: 10.1200/JCO.2002.20.1.9. J Clin Oncol. 2002. PMID: 11773148

4

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.

Sundararajan V, Hershman D, Grann VR, Jacobson JS, Neugut AI. Sundararajan V, et al. J Clin Oncol. 2002 Jan 1;20(1):173-8. doi: 10.1200/JCO.2002.20.1.173. J Clin Oncol. 2002. PMID: 11773167

5

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Grann VR, et al. J Clin Oncol. 2002 May 15;20(10):2520-9. doi: 10.1200/JCO.2002.10.101. J Clin Oncol. 2002. PMID: 12011131

6

Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

Hershman D, Weinberg M, Rosner Z, Alexis K, Tiersten A, Grann VR, Troxel A, Neugut AI. Hershman D, et al. J Natl Cancer Inst. 2003 Oct 15;95(20):1545-8. doi: 10.1093/jnci/djg073. J Natl Cancer Inst. 2003. PMID: 14559877

7

Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study.

Hershman D, Fleischauer AT, Jacobson JS, Grann VR, Sundararajan V, Neugut AI. Hershman D, et al. Gynecol Oncol. 2004 Jan;92(1):293-9. doi: 10.1016/j.ygyno.2003.10.006. Gynecol Oncol. 2004. PMID: 14751173

8

Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.

Hershman D, Jacobson JS, McBride R, Mitra N, Sundararajan V, Grann VR, Neugut AI. Hershman D, et al. Gynecol Oncol. 2004 Aug;94(2):540-9. doi: 10.1016/j.ygyno.2004.04.022. Gynecol Oncol. 2004. PMID: 15297201

9

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI. Grann VR, et al. Cancer. 2005 Jun 1;103(11):2241-51. doi: 10.1002/cncr.21030. Cancer. 2005. PMID: 15844176 Free article.

10

Barriers to minority participation in breast carcinoma prevention trials.

Grann VR, Jacobson JS, Troxel AB, Hershman D, Karp J, Myers C, Neugut AI. Grann VR, et al. Cancer. 2005 Jul 15;104(2):374-9. doi: 10.1002/cncr.21164. Cancer. 2005. PMID: 15937913 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

631 results

Search Page

Filters